Monday 20 September 2021 1:57 pm

15,000 Brits who took part in Novavax trials unable to prove Covid vaccine status

Ministers are being urged to help thousands of people who took part in Covid-19 vaccine trials who cannot prove their vaccination status.

Trial participants have described being “trapped” and “in limbo” because they are unable to get a licensed Covid-19 vaccine or travel abroad.

Around 15,000 Britons took part in the Novavax Covid-19 vaccine clinical trial. The vaccine is yet to be approved for use in the UK.

People who took part have said that despite being vaccinated, and volunteering to enhance medical science early on in the pandemic, they are unable to enjoy the same freedoms as the general population.


A petition has been launched on calling for help from Health Secretary Sajid Javid.

The petition, launched by the Novavax UK Concerned Participants Group, states that UK volunteers are “significantly disadvantaged” because they face barriers to travel and are unable to get another Covid-19 vaccine.

“We call on the ministers to rectify the situation immediately so that Novavax volunteers can travel as freely as other vaccinated people,” the petition states.

Retiree Gill Ince, who participated in the trial in September 2020, said she felt like she was “living in limbo”.

The 61-year-old, from Oxfordshire, said: “I stepped forward early in the pandemic to participate in a vaccine trial.

“I wanted to do my bit to fight Covid but I feel utterly betrayed by the system and I’m trapped without any vaccination status.

“I was given reassurances that I would not be disadvantaged in anyway at a later date. We have no idea if, where or when Novavax will be approved so now we are living in limbo. It’s incredibly stressful and I feel like a prisoner.

“It feels like the most awful situation I’ve ever been put in in my life, because I can’t do anything.”

The Observer reported on Sunday that England’s deputy chief medical officer Professor Jonathan Van-Tam suggested to the Government that the UK withhold clinical trial data if vaccine trial participants were not being allowed into European countries.